Skip to Content

4833M 15/850 (Actoplus Met 850 mg / 15 mg)

Generic Name: metformin/pioglitazone

Pill with imprint 4833M 15/850 is White, Elliptical / Oval and has been identified as Actoplus Met 850 mg / 15 mg. It is supplied by Takeda Pharmaceuticals America, Inc..

ActoPlus Met is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. ActoPlus Met 850 mg / 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 4833M 15/850

Actoplus met 850 mg / 15 mg 4833M 15/850
Actoplus met 850 mg / 15 mg 4833M 15/850 Front
Actoplus met 850 mg / 15 mg 4833M 15/850 Back
Actoplus met 850 mg / 15 mg 4833M 15/850

Actoplus Met

Generic Name
metformin/pioglitazone
Imprint
4833M 15/850
Strength
850 mg / 15 mg
Color
White
Size
18.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Antidiabetic combinations
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Takeda Pharmaceuticals America, Inc.
Inactive Ingredients
microcrystalline cellulose, croscarmellose sodium, magnesium stearate, hypromellose 2910 (6 mPa.s), polyethylene glycol 8000, titanium dioxide, magnesium silicate

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
64764-0158 Takeda Pharmaceutical Company Limited
00093-5050 Teva Pharmaceuticals USA, Inc.
42291-0694 AvKare, Inc.
54868-5553 Physicians Total Care Inc. (repackager)
35356-0130 Lake Erie Medical and Surgical Supply (repackager)

Get help with Imprint Code FAQs.

Related Images for "4833M 15/850"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.